Plasma D-dimer concentration in patients with systemic sclerosis

British Journal of Dermatology

Volumn 158, Issue 2, 2008, Pages 392-395

  Marie, I ^a   Borg, J Y ^a   Hellot, M F ^a   Levesque, H ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Macrovascular involvement; Plasma D dimer; Plasminogen activator inhibitor; Risk factor; Systemic sclerosis

Indexed keywords

D DIMER;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN INACTIVATORS; SCLERODERMA, SYSTEMIC; VASCULAR DISEASES;

EID: 38349156967     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08313.x     Document Type: Article

References (18)

1. Leroy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996 22 : 675 94.
2. Marie I, Beny JL. Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1. J Invest Dermatol 2002 119 : 1379 87.
3. Servettaz A, Agard C, Tamby MC et al. Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes. Presse Med 2006 35 : 1903 15.
4. Matucci-Cerinic M, Kahaleh MB, Leroy EC. Vascular involvement in systemic sclerosis. In : Systemic Sclerosis (Clements PJ, Furst DE, eds). Baltimore : Williams & Wilkins, 1996 153 74.
5. Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970 73 : 317 24.
6. Prescott RJ, Fremont AJ, Jones CJP et al. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992 166 : 255 63.
7. Ames PR, Lupoli S, Alves J et al. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol 1997 36 : 1045 50.
8. Falanga V, Kruskal JB, Franks JJ. Fibrin and fibrinogen-related antigens in systemic sclerosis (scleroderma). J Am Acad Dermatol 1991 25 : 771 5.
9. Lippi G, Volpe A, Caramaschi P et al. Plasma D-dimer concentration in patients with systemic sclerosis. Thromb J 2006 4 : 2.
10. Maeda M, Kachi H, Mori S. Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS). J Dermatol Sci 1996 11 : 223 7.
11. Komarov A, Panchenko EP, Dobrovolsky AB et al. D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease. Eur Heart J 2002 23 : 1309 16.
12. Lowe GDO. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006 133 : 232 50.
13. Morange PE, Bickel C, Nicaud V et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 2006 26 : 2793 9.
14. Nylaende M, Kroese A, Stranden E et al. Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease. Thromb Haemost 2006 95 : 702 7.
15. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007 115 : 996 1003.
16. Stegnar M, Vene N, Bozic M. Do haemostasis activation markers that predict cardiovascular disease exist? Pathophysiol Haemost Thromb 2003 33 : 302 8.
17. Tzoulaki I, Murray GD, Price JF et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis. The Edinburgh Artery Study. Am J Epidemiol 2006 163 : 334 41.
18. Leroy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988 15 : 202 5.